111 – 120 of 155
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
The grade in physical education in adolescence as predictor for musculoskeletal pain diagnoses three decades later.
(
- Contribution to journal › Article
-
Mark
Team-based rehabilitation improves long-term aerobic capacity and health-related quality of life in patients with chronic inflammatory arthritis.
(
- Contribution to journal › Article
-
Mark
Cost of Illness from the Public Payers' Perspective in Patients with Ankylosing Spondylitis in Rheumatological Care.
(
- Contribution to journal › Article
-
Mark
Differences In The Rate Of Hip Fracture In Patients With Ankylosing Spondylitis And Hip Osteoarthritis Compared With General Population Seeking Health Care
(
- Contribution to journal › Published meeting abstract
-
Mark
Utility-based outcomes made easy: The number needed per QALY gained (NNQ). Observational cohort study from Southern Sweden of TNF blockade in inflammatory arthritis.
(
- Contribution to journal › Article
-
Mark
How to Develop Patient-Centered Research: Some Perspectives Based on Surveys Among People With Rheumatic Diseases in Scandinavia
(
- Contribution to journal › Article
-
Mark
Reduced Rate Of Hip Fracture In Patients With Hip Or Knee Osteoarthritis
2010) World Congress of the OsteoArthritis-Research-Society-International In Osteoarthritis and Cartilage 18. p.131-131(
- Contribution to journal › Published meeting abstract
-
Mark
Presence of peripheral arthritis and male sex predicting continuation of anti–tumor necrosis factor therapy in ankylosing spondylitis: An observational prospective cohort study from the South Swedish arthritis treatment group register
(
- Contribution to journal › Article
-
Mark
Rapid and sustained health utility gain in anti-TNF treated inflammatory arthritis. Observational data during seven years in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort study.
(
- Contribution to journal › Article